🚨 'Disaster waiting to happen': FDA approves phase 1 trial of Gates-funded self-amplifying bird flu vaccine

Health

Clinical trials — funded by the U.S. government and the Bill & Melinda Gates Foundation — are set to begin for a self-amplifying mRNA vaccine targeting the H5N1 bird flu virus. Arcturus Therapeutics announced earlier this week that the U.S. Food and Drug Administration (FDA) issued a "Study Can Proceed" notification for its investigational ARCT-2304 vaccine candidate. Epidemiologist Nicolas Hulscher told The Defender the FDA's notification "means Arcturus Therapeutics can begin its "experiment of injecting humans with H5N1 bird flu replicon mRNA." Self-amplifying mRNA injections contain an enzyme that instructs the body on how to make more mRNA. Arcturus says the vaccine is "formulated within a lipid nanoparticle"

SOTT     Nov 20, 2024